Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Plasma complement biomarkers distinguish multiple sclerosis and neuromyelitis optica spectrum disorder.
Symptom Management and Lifestyle Modifications in Multiple Sclerosis.
Mobitz type I and II atrioventricular blocks during fingolimod therapy.
Rifampicin attenuates experimental autoimmune encephalomyelitis by inhibiting pathogenic Th17 cells responses.
MRI Patterns of Isolated Lesions in the Medulla Oblongata.
Decreased arylesterase activity of paraoxonase-1 (PON-1) might be a common denominator of neuroinflammatory and neurodegenerative diseases.
Automated multi-objective calibration of biological agent-based simulations.
The effects of fatigue, depression and the level of disability on the health-related quality of life of glatiramer acetate-treated relapsing-remitting patients with multiple sclerosis in Hungary.
Effect of dual-task-induced uncertainty on gait biomechanics in patients with multiple sclerosis with 2-6.5 EDSS grade.
High glucocorticoid levels during gestation activate the inflammasome in hippocampal oligodendrocytes of the offspring.
Textured and stimulating insoles for balance and gait impairments in patients with multiple sclerosis and Parkinson's disease: A systematic review and meta-analysis.
Cellular mechanisms of adaptive myelination: bridging the gap between animal studies and human cognition.
Comparative evaluation of patients' and physicians' satisfaction with interferon beta-1b therapy.
Thalamocortical-auditory network alterations following cuprizone-induced demyelination.
Drinking away fatigue in multiple sclerosis.
Cholinergic system and neuroinflammation: Implication in multiple sclerosis.
Radiologically isolated syndrome: An update on a rare entity.
Commentary on painful tonic spasms and brainstem involvement in a patient with neuromyelitis optica spectrum disorder.
Role of IL-17-producing lymphocytes in severity of multiple sclerosis upon natalizumab treatment.
Fampridine and quality of life in individuals with multiple sclerosis.
Protein Citrullination: A Proposed Mechanism for Pathology in Traumatic Brain Injury.
Hypofrontality and Posterior Hyperactivity in Early Schizophrenia: Imaging and Behavior in a Preclinical Model.
Rebound Syndrome in Multiple Sclerosis After Fingolimod Cessation.
[Cell depletion and myoablation for neuroimmunological diseases].
Improvement of neurological disorders in postmenopausal model rats by administration of royal jelly.
Pages
« first
‹ previous
…
773
774
775
776
777
778
779
780
781
…
next ›
last »